Its mechanisms may involve promoting renal fibrosis through oxidative stress and inflammatory pathways and further aggravating DN progression by influencing PM‐RGs such as KAZALD1, GLCE, and RPRD1B. The gene discussed is RPRD1B; the disease is liver dysplastic nodule.